These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 279972)

  • 1. A review of models for the therapy of experimental infections.
    Bergeron MG
    Scand J Infect Dis Suppl; 1978; (14):189-206. PubMed ID: 279972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critique of animal models in antibiotic research.
    Barza M
    Scand J Infect Dis Suppl; 1978; (14):109-17. PubMed ID: 279963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental pyelonephritis in rats: value in the comparison of antibiotics (author's transl)].
    Videau D
    Ann Microbiol (Paris); 1976 Oct; 127B(3):337-50. PubMed ID: 798516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of therapy in animal models to bacterial infection in human disease.
    Tunkel AR; Scheld WM
    Infect Dis Clin North Am; 1989 Sep; 3(3):441-59. PubMed ID: 2504810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction into antibiotic combination treatment.
    Ellorhaoui M
    Ther Hung; 1978; 26(1):3-11. PubMed ID: 663873
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunocompromised animal models for the study of antibiotic combinations.
    Calandra T; Glauser MP
    Am J Med; 1986 May; 80(5C):45-52. PubMed ID: 3087166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between antimicrobial consumption and selection of resistant bacterial strains.
    Moellering RC
    Scand J Infect Dis Suppl; 1990; 70():18-24. PubMed ID: 2287899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors on antimicrobials].
    Totsuka K
    Nihon Rinsho; 1994 Feb; 52(2):339-43. PubMed ID: 8126882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacterial spectrum and pathogen resistance in chronic primary and secondary pyelonephritis].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Aug; 75(8):579-85. PubMed ID: 6758412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.
    Møller JK
    Dan Med Bull; 1990 Jun; 37(3):263-74. PubMed ID: 2192838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.
    Barriere SL
    Pharmacotherapy; 1992; 12(5):397-402. PubMed ID: 1437700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host resistance to intracellular parasites and its influence on the efficacy of antibiotic therapy.
    Hormaeche CE
    J Chemother; 1989 Jul; 1(4 Suppl):413-5. PubMed ID: 16312463
    [No Abstract]   [Full Text] [Related]  

  • 16. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is a repeat treatment of antibiotic therapy necessary?].
    Seeger K
    Tierarztl Prax; 1988; 16(2):109-12. PubMed ID: 3047908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial resistance after antibiotic use in animals--impact on human health].
    Sundsfjord A; Sunde M
    Tidsskr Nor Laegeforen; 2008 Nov; 128(21):2457-61. PubMed ID: 19096469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.